Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical managementVOSE, Julie M.American journal of hematology. 2012, Vol 87, Num 6, pp 605-609, issn 0361-8609, 5 p.Article

Purine analogues in the treatment of lymphoid malignanciesFOSS, Francine; VOSE, Julie M.Seminars in hematology. 2006, Vol 43, Num 2, issn 0037-1963, 56 p., SUP2Conference Proceedings

Management of indolent lymphoma: Where are we now and where are we goingLUNNING, Matthew A; VOSE, Julie M.Blood reviews. 2012, Vol 26, Num 6, pp 279-288, issn 0268-960X, 10 p.Article

Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemiaKAY, Neil E.Seminars in hematology. 2006, Vol 43, Num 2, issn 0037-1963, S50-S54, SUP2Conference Paper

Role of single-agent purine analogues in therapy of peripheral T-cell lymphomasDEARDEN, Claire E.Seminars in hematology. 2006, Vol 43, Num 2, issn 0037-1963, S22-S26, SUP2Conference Paper

Dendritic cell-based therapy for mantle cell lymphomaMUNGER, Corey M; VOSE, Julie M; JOSHI, Shantaram S et al.International journal of oncology. 2006, Vol 28, Num 6, pp 1337-1343, issn 1019-6439, 7 p.Article

Purine analogues in advanced T-cell lymphoid malignanciesKURZROCK, Razelle; RAVANDI, Farhad.Seminars in hematology. 2006, Vol 43, Num 2, issn 0037-1963, S27-S34, SUP2Conference Paper

Angioimmunoblastic T-Cell Lymphoma ManagementMOSALPURIA, Kailash; BOCIEK, R. Gregory; VOSE, Julie M et al.Seminars in hematology. 2014, Vol 51, Num 1, pp 52-58, issn 0037-1963, 7 p.Article

CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphomaMITROVIC, Zdravko; IQBAL, Javeed; CHAN, Wing C et al.British journal of haematology. 2013, Vol 162, Num 1, pp 87-92, issn 0007-1048, 6 p.Article

Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy StudyPICCALUGA, Pier Paolo; FULIGNI, Fabio; MANNU, Claudia et al.Journal of clinical oncology. 2013, Vol 31, Num 24, pp 3019-3025, issn 0732-183X, 7 p.Article

Human Immunodeficiency Virus-Associated Plasmablastic Lymphoma: Poor Prognosis in the Era of Highly Active Antiretroviral TherapyCASTILLO, Jorge J; FURMAN, Michael; NANAJI, Nahid M et al.Cancer. 2012, Vol 118, Num 21, pp 5270-5277, issn 0008-543X, 8 p.Article

Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphomaMUNGER, Corey M; HEGDE, Ganapati V; WEISENBURGER, Dennis D et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 10, pp 1819-1832, issn 0340-7004, 14 p.Article

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?BACHER, Ulrike; KLYUCHNIKOV, Evgeny; GALE, Robert Peter et al.Blood. 2012, Vol 120, Num 20, pp 4256-4262, issn 0006-4971, 7 p.Article

Integrated profiling of diffuse large B-cell lymphoma with 7q gainCHIGRINOVA, Ekaterina; MIAN, Michael; FERRERI, Andrés J. M et al.British journal of haematology. 2011, Vol 153, Num 4, pp 499-503, issn 0007-1048, 5 p.Article

Peripheral T-cell lymphomaFOSS, Francine M; LUIGI ZINZANI, Pier; VOSE, Julie M et al.Blood. 2011, Vol 117, Num 25, pp 6756-6767, issn 0006-4971, 12 p.Article

The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological originCZUCZMAN, Myron S; VOSE, Julie M; WITZIG, Thomas E et al.British journal of haematology. 2011, Vol 154, Num 4, pp 477-481, issn 0007-1048, 5 p.Article

ALK^-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK⁺ ALCL and peripheral T-cell lymphoma, not otherwise specified : report from the International Peripheral T-Cell Lymphoma ProjectSAVAGE, Kerry J; LEE HARRIS, Nancy; ARMITAGE, James O et al.Blood. 2008, Vol 111, Num 12, pp 5496-5504, issn 0006-4971, 9 p.Article

Revised response criteria for malignant lymphomaCHESON, Bruce D; PFISTNER, Beate; ROSEN, Steven T et al.Journal of clinical oncology. 2007, Vol 25, Num 5, pp 579-586, issn 0732-183X, 8 p.Article

Outcomes After Hematopoietic Stem-Cell Transplantation for Hematologic Malignancies in Patients With or Without Advance Care PlanningKISHOR GANTI, Apar; LEE, Stephanie J; VOSE, Julie M et al.Journal of clinical oncology. 2007, Vol 25, Num 35, pp 5643-5648, issn 0732-183X, 6 p.Article

Molecular diagnosis of Burkitt's lymphomaDAVE, Sandeep S; KAI FU; MÜLLER-HERMELINK, Hans-Konrad et al.The New England journal of medicine. 2006, Vol 354, Num 23, pp 2431-2442, issn 0028-4793, 12 p.Article

Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphomaFORERO, Andres; WEIDEN, Paul L; SIMS, Robert B et al.Blood. 2004, Vol 104, Num 1, pp 227-236, issn 0006-4971, 10 p.Article

Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's diseaseGILES, Francis J; VOSE, Julie M; ARMITAGE, James O et al.British journal of haematology. 2003, Vol 123, Num 5, pp 850-857, issn 0007-1048, 8 p.Article

Lymphoma diagnosis at an academic centre: rate of revision and impact on patient careBOWEN, Joslin M; PERRY, Anamarija M; CHAN, Wing C et al.British journal of haematology. 2014, Vol 166, Num 2, pp 202-208, issn 0007-1048, 7 p.Article

Clinicopathologic Characteristics of Angioimmunoblastic T-Cell Lymphoma: Analysis of the International Peripheral T-Cell Lymphoma ProjectFEDERICO, Massimo; RUDIGER, Thomas; WEISENBURGER, Dennis D et al.Journal of clinical oncology. 2013, Vol 31, Num 2, pp 240-246, issn 0732-183X, 7 p.Article

Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOPXIN HUANG; BIN MENG; WEISENBURGER, Dennis D et al.Journal of clinical oncology. 2013, Vol 31, Num 36, pp 4520-4528, issn 0732-183X, 9 p.Article